Design Therapeutics, Inc.
Design Therapeutics, Inc. (DSGN) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 51 transactions totaling $93.9M, demonstrating a bullish sentiment with $58.5M in net insider flow. The most recent transaction on Jan 2, 2026 involved a transaction of 750,000 shares valued at $0.
DSGN Insider Activity Summary
Who Is Buying DSGN Stock?
No significant insider buying has been recorded for DSGN in the recent period.
Who Is Selling DSGN Stock?
No significant insider selling has been recorded for DSGN in the recent period.
Is Design Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DSGN is bullish with an Insider Alignment Score of 81/100 and a net flow of $58.5M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
DSGN Frequently Asked Questions
Understanding DSGN Insider Activity
Insider trading at Design Therapeutics, Inc. (DSGN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading DSGN stock, having executed 51 transactions in the past 90 days. The most active insider is Arsani William (Executive), who has made 13 transactions totaling $40.9M.
Related Tools
Track Design Therapeutics, Inc. Insider Activity
Get notified when executives and directors at DSGN file new Form 4 transactions